Synthesis of new N-sulfonyl monocyclic β-lactams and the investigation of their antibacterial activities

Phosphorus, Sulfur and Silicon and the Related Elements

Volumn 185, Issue 2, 2010, Pages 287-297

  Jarrahpour, Aliasghar ^a   Motamedifar, Mohammad ^b   Zarei, Maaroof ^a   Mimouni, Mostafa ^c  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

2 azetidinones; Antibacterial activity; Imines; Ketenes; N sulfonyl lactams; Staudinger reaction

Indexed keywords

EID: 77951245065     PISSN: 10426507     EISSN: 15635325     Source Type: Journal    
DOI: 10.1080/10426500902773161     Document Type: Article

References (53)

1. M. I. Page, The Chemistry of β-Lactams (Blackie Academic and Professional, New York, 1992).
2. R. Southgate, C. Branch, S. Coulton, and E. Hunt, Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products (Springer-Verlag, Berlin, 1993), vol.2, p. 621.
3. D. T. W. Chu, J. I. Ptattner, and L. Katz, J. Med. Chem., 39, 3853 (1996).
4. A. G. Brown, Pure Appl. Chem., 59, 475 (1987).
5. J. E. Bladwin and M. Bradley, Chem. Rev., 90, 1079 (1990).
6. W. Durcheimer, J. Blumbach, R. Lattrell, and K. H. Scheunamann, Angew. Chem. Int. Ed. Engl., 24, 25 (1985).
7. J. E. Rode and J. C. Dobrowoski, J. Mol. Struct., 651, 705 (2003).
8. A. A. Jarrahpour, M. Shekarriz, and Taslimi, Molecules, 9, 29 (2004).
9. A. A. Jarrahpour, M. Shekarriz, and Taslimi, Molecules, 9, 939 (2004).
10. R. Gonzalez-Muniz, E. De Clercq, J. Balzarini, G. G. Navarro, J. P. De Vega, C. Anderi, T. Garcia-Lopez, and R. Snoeck, Bioorg. Med. Chem. Lett., 14, 2253 (2004).
11. J. C. Powers, J. L. Asgian, O. D. Ekici, and K. B. E. James, Chem. Rev., 102, 4693 (2002).
12. J. C. Sutton, S. A. Bolton, K. S. Harti, M. H. Huang, G. Jacobs, W. Meng, G. Zhao, and G. S. Bisacchi, Bioorg. Med. Chem. Lett., 14, 2233 (2004).
13. M. Bengalia, R. Annunziata, M. Clinquini, and F. Cozzi, J. Org. Chem., 68, 2952 (2003).
14. C. M. L. Delpiccolo and E. G. Mata, Tetrahedron Lett., 45, 4085 (2004).
15. D. A. Burnett, M. A. Caplen, J. W. Clader, and H. R. Davis, Bioorg. Med. Chem. Lett., 12, 311 (2002).
16. J. Marchand-Brynaert, G. Dive, M. Galleni, and S. Gerard, Bioorg. Med. Chem., 12, 129 (2004).
17. S. Gerard, G. Dive, B. Clamet, R. Touillaux, and J. Marchand-Brynaert, Tetrahedron, 58, 2423 (2002).
18. W. Bode, E. F. Meyer, and J. C. Powers, Biochemistry, 28, 1951 (1989).
19. E. L. Setti, D. Davis, J.W. Janc, D. A. Jeffery, H. Cheung, andW. Yu, Bioorg. Med. Chem. Lett., 15, 1529 (2005).
20. E. L. Setti, D. Davis, and J. Mc Carter, Bioorg. Med. Chem. Lett., 13, 2051 (2003).
21. B. K. Banik, F. F. Becker, and I. Banik, Bioorg. Med. Chem., 12, 2523 (2004).
22. I. Banik, F. F. Becker, B. K. Banik, J. Med. Chem., 46, 12 (2003).
23. L. Kuznetsova, I. Ojima, X.Wu, I. M. Ungureanu, I. Zanardi, and A. Pepe, J. Flour. Chem., 125, 487 (2004).
24. B. Alcaide and P. Almendros, Chem. Soc. Rev., 30, 226 (2001).
25. M. Botta, F. Corell, S. Armaroli, and D. Castagnolo, Tetrahedron: Asymmetry, 15, 941 (2004).
26. B. Alcaide and P. Almendros, Synlett, 381 (2002).
27. C. Palomo, J. M. Aizupura, I. Ganoba, and M. Oiarbide, Synlett, 1813 (2001).
28. A. Halve and A. Goyal, Orient. J. Chem., 12, 87 (1996).
29. R. X. Ren, M. I. Konaklieva, H. Shi, D. V. Lim, E. Turos, J. Gonzalez, and S. Dickey, J. Org. Chem., 63, 8898 (1998).
30. A. Jarrahpour and M. Zarei, Molecules, 11, 49 (2006).
31. D. Freitag, P. Schwab, and P. Metz, Tetrahedron Lett., 45, 3589 (2004).
32. E.Turos,M. I.Konaklieva, R. X. Ren, D. V. Lim, H. Shi, J. Gonzalez, andS. Dickey, Tetrahedron, 56, 5571 (2000).
33. E. Turos and T. E. Long, Curr Med Chem.-Anti-Infective Agents, 1, 251 (2002).
34. M. I. Konaklieva, H. Shi, and E. Turos, Tetrahedron Lett., 38, 8647 (1997).
35. G. S. Singh, Tetrahedron, 59, 7631 (2003).
36. C. Palomo, J. M. Aizpurua, L. Ganboa, and M. Oiarbide, Eur. J. Org. Chem., 3223 (1999).
37. D. Vankoten and F. H. Vander Steen, Tetrahedron, 47, 7503 (1991).
38. J. Xu, ARKIVOC, ix, 21 (2009).
39. A. Jarrahpour and M. Zarei, Molecules, 12, 2364 (2007).
40. A. Jarrahpour and M. Zarei, Tetrahedron Lett., 48, 8712 (2007).
41. H. Staudinger, Liebigs Ann. Chem., 51, 356 (1907).
42. J. R. Lopez, J. C. G. Martinez, and E. D. Barra, Synlett, 1587 (2003).
43. P. D. Buttero, G. Molteni, and A. Papagani, Tetrahedron: Asymmetry, 14, 3949 (2003).
44. Y. Kumar, N. Tewari, H. Nizar, and S. K. Singh, Org. Process Res. Develop., 7, 933 (2003).
45. A. Jarrahpour and D. Khalili, Tetrahedron Lett., 48, 7140 (2007).
46. C. La Rosa, P. D. Croce, and G. Cremonesi, Tetrahedron, 60, 93 (2004).
47. G. H. Hakimelahi and A. A. Jarrahpour, Helv. Chim. Acta, 72, 1501 (1989).
48. H. K. Lee, J. S. Chung, and C. S. Peak, Tetrahedron, 59, 6445 (2003).
49. A. Jarrahpour and M. Zarei, Synlett, 381 (2008).
50. T. W. Green and P. G. M. Wuts, Green's Protective Group in Organic Synthesis, 4th ed. (John Wiley & Sons, New York, 2007), p. 903.
51. B. A. Forbes, D. F. Sham, and A. S. Weissfeld, Bailey & Scott's Diagnostic Microbiology, 11th ed. (Mosby Inc., St. Louis, MO, 2002).
52. R. C. Lyman and K. C. C. Yang, J. Chem. Eng. Data, 13, 291 (1968).
53. Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3-,4-- di-substituted -4-H-spiro[isothiochromene-3,5--isoxazol]- 4(1H)-one. B. Bennani, A. Kerbal, M. Daoudi, B. Filali Baba, G. Al Houari, A. F. Jalbout, M. Mimouni, M. Benazza, G. Demailly, M. Akkurt, S. öztürk Yýldýrým, and T. Ben Hadda, ARKIVOC, xvi, 19 (2007).